With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved significantly over the past few years, claims Roots Analysis

The Contract Manufacturing Market for Live Biotherapeutics And Microbiome Products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Presently, there are more than 10 approved gene therapies; over 465 product candidates are being evaluated for the treatment of a variety of disease indications

The Bispecific Antibody Therapeutics Market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

The contract manufacturing market for live Biotherapeutics and Microbiome Products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

The Large Volume Wearable Injectors Market is estimated to be worth around USD 600 million by 2030, predicts Roots Analysis

The Global Handheld Ultrasound Imaging Devices Market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis

The Gene Therapy Market is projected to grow at an annualized rate of 45%, till 2030

The Bispecific Antibody Therapeutics Market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

Oligonucleotide Synthesis, Modification and Purification Services Market, Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030”

The “Companion Diagnostics Development Services Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade...

Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees, claims Roots Analysis

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis

The “Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs ...

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis

Over 180 companies from different regions across the globe presently claim to provide services for the development of companion diagnostic tests, claims Roots Analysis

Patient Recruitment and Retention Services Market is projected to grow at an annualized rate of ~5%, till 2030

More than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation, for a wide range of ophthalmic APIs and drug FDFs, claims Roots Analysis

The Oligonucleotide Synthesis, Modification and Purification Services Market is projected to grow at an annualized rate of ~10%, till 2030

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030

The Prefilled Syringe Fill / Finish Services Market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis

The Patient Recruitment and Retention Services Market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis

The Ophthalmic Drugs Contract Manufacturing Market is projected to grow at an annualized rate of ~8%, till 2030

The Oligonucleotide Synthesis, Modification And Purification Services Market is estimated to be worth USD 5.8 billion in 2030, predicts Roots Analysis

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise.

The “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030

The “HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the manufacturing of HPAPIs and cytotoxic drugs over the next decade.

The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade.

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

Over 90 firms are actively involved in providing in silico services for drug discovery of different types of biologics; of these, over 30 players claim to have the capabilities to offer services for all steps of discovery

Close to 120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services for HPAPIs and cytotoxic drugs, claims Roots Analysis

Over 85 firms are involved in providing fragment-based drug discovery-related services; of these, around 40 players claim to offer both libraries and technologies

The Neoantigen Targeted Therapies Market is projected to grow at an annualized rate of 57%, till 2030

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis

The Fragment-Based Drug Discovery Market is projected to grow at an annualized rate of ~10%, till 2030

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis

Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030